DiaSorin S.p.A.

DIA

IT0003492391

Medical Equipment, Supplies & Distribution

Market Closed - Borsa Italiana Other stock markets 11:44:59 2024-09-10 am EDT			5-day change	1st Jan Change
104.00 ^EUR	0.00%		+2.87%	+11.54%

Sep. 10	Business Square up; UK unemployment falls	AN
Sep. 10	Futures little moved; Germany inflation at 1.9 percent	AN

Presentation Operator MessageOperator (Operator)Good afternoon. This is the Chorus Call confer...

This article is reserved for subscribers

Signed up already?

Not subscribed yet?

Latest news about DiaSorin S.p.A.

Business Square up; UK unemployment falls	Sep. 10	AN
Futures little moved; Germany inflation at 1.9 percent	Sep. 10	AN
Mib up, traders await central banks	Sep. 09	AN
DiaSorin launches new Liaison antigen test in countries with CE	Sep. 09	AN
Indices up; EU recession fears for Sentix	Sep. 09	AN
Indices up; UniCredit tops the Mib	Sep. 09	AN
Funds move on Iveco, DiaSorin and STM.	Sep. 06	AN
Stock exchanges in the red at start; oil weighed down	Sep. 05	AN
Funds operate on BPER, DiaSorin, Italgas and Saipem.	Sep. 04	AN
Lists up tentatively; traders await data	Sep. 03	AN
Mib in red; Leonardo ends at bottom	Sep. 02	AN
Milan stock market weak, session without cues with WS closed, banks good, Juve slumps on realizations	Sep. 02	RE
Futures await contrasting stock markets	Aug. 29	AN
Mib advances to 33,800; Recordati and DiaSorin on top	Aug. 28	AN
Milan bullish; DiaSorin takes top spot	Aug. 28	AN
Stock markets in green ahead of Powell; banks good on Mib	Aug. 23	AN
DiaSorin, annulment of administrative penalty imposed by CONSOB	Aug. 23	AN
Global markets live: Diageo, Apple, Tesla, Meta Platforms, PayPal, Pfizer...	Jul. 30
DIASORIN : Q2 profitability beat; lower end of guidance upgraded	Jul. 30
Piazza Affari up; Campari hurt after accounts	Jul. 30	AN
Mib in green; half-yearly publication pushes Poste	Jul. 30	AN
Futures flat; France GDP better than expected	Jul. 30	AN
DiaSorin S.p.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	Jul. 29	CI
Mib closes lower, down Campari and Nexi	Jul. 29	AN
Global markets live: Apple, 3M Company, Boeing, Honeywell...	Jul. 29

DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc. At the end of 2023, the group had 10 production sites located in Italy, the United States (6), Canada, Germany, and the United Kingdom.

Employees

3,186

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-11-14 - Q3 2024 Earnings Release

Related indices

FTSE MIB INDEX

More about the company